世界の生体用医薬品市場の成長（現状と展望）2023-2029年

Global Living Biological Drugs Market Growth (Status and Outlook) 2023-2029

LPI（エルピーアイ）社の最新調査レポート「リビングバイオロジカルドラッグ産業予測」は、過去の販売実績から2022年の世界のリビングバイオロジカルドラッグの総販売実績を検証し、2023年から2029年のリビングバ... もっと見る

出版社	出版年月	電子版価格	ページ数	言語
LP Information LPインフォメーション	2023年2月9日	US$3,660 シングルユーザライセンスライセンス・価格情報注文方法はこちら	122	英語

目次
図表リスト

サマリー

LPI（エルピーアイ）社の最新調査レポート「リビングバイオロジカルドラッグ産業予測」は、過去の販売実績から2022年の世界のリビングバイオロジカルドラッグの総販売実績を検証し、2023年から2029年のリビングバイオロジカルドラッグの販売予測について地域と市場分野別に包括的に分析しています。本レポートでは、生物学的製剤の売上を地域別、市場分野別、サブセクター別に分類し、世界の生物学的製剤産業の詳細な分析（百万ドル単位）を提供します。
本インサイトレポートでは、世界のリビングバイオロジカルドラッグの状況を包括的に分析し、製品区分、会社設立、収益、市場シェア、最新開発、M&A活動に関する主要動向を明らかにしています。また、本レポートでは、加速する世界のリビングバイオロジカルドラッグ市場におけるこれらの企業の独自のポジションをより良く理解するために、リビングバイオロジカルドラッグのポートフォリオと能力、市場参入戦略、市場ポジション、地理的フットプリントに焦点を当てて、主要グローバル企業の戦略を分析しています。
本インサイトレポートでは、リビングバイオロジカルドラッグの世界的な見通しを形成する主要な市場動向、推進要因、影響要因を評価し、タイプ別、アプリケーション別、地域別、市場規模別に予測を行い、新たな機会のポケットを明らかにします。何百ものボトムアップの定性的・定量的な市場インプットに基づく透明性の高い手法により、この調査予測は、世界のリビングバイオロジカルドラッグの現状と将来の軌道について非常にニュアンスのある見方を提供します。
世界のリビングバイオロジカルドラッグの市場規模は、2022年の100万米ドルから2029年には100万米ドルに成長すると予測され、2023年から2029年までの年平均成長率は％であると予想されます。
リビングバイオロジカルドラッグの米国市場は、2023年から2029年までのCAGR %で、2022年の百万米ドルから2029年には百万米ドルに増加すると予測されます。
中国市場は、2023年から2029年までの年平均成長率で、2022年の百万米ドルから2029年には百万米ドルに増加すると推定されます。
生物学的製剤のヨーロッパ市場は、2023年から2029年にかけてのCAGR %で、2022年の百万米ドルから2029年には百万米ドルに増加すると推定されています。
世界の主要なリビングバイオロジカルドラッグのプレーヤーは、Ardeypharman、Miyarisan Pharmaceutical、Ferring Pharmaceuticals、Seres Therapeutics、Infant Bacterial Therapeutics、Osel、Takeda、AOBiome、Synlogicなどです。収益面では、世界の2大企業が2022年にほぼ％のシェアを占めています。
本レポートでは、生物由来医薬品市場の製品タイプ、用途、主要プレイヤー、主要地域、国別の包括的な概要、市場シェア、成長機会について紹介します。
市場のセグメンテーション
タイプ別セグメンテーション
シングルストレイン
マルチストレイン
コ・カルチャー
アプリケーション別セグメント
消化器系
泌尿器系
スキンシステム
また、本レポートでは、市場を地域別に分類しています：
米州
ユーエスエー
カナダ
メキシコ
ブラジル
APAC
中国
日本
韓国
東南アジア
インド
オーストラリア
ヨーロッパ
ドイツ
フランス
連邦王国
イタリア
ロシア
中近東・アフリカ
エジプト
南ア
イスラエル
トルコ
GCC諸国
以下の企業は、主要な専門家から収集した情報、企業のカバレッジ、製品ポートフォリオ、市場浸透度を分析した上で選ばれています。
アーデイファーマン
ミヤリサン製薬
フェリング・ファーマシューティカルズ
セレス・セラピューティクス
乳幼児用細菌治療薬
オセル
武田
アオビオメ
シンロジック
フィンチ・セラピューティクス
カプシュゲル
ジェネイル・バイオテック
UAS Labs
ビオース
セルビオス・ファーマ
インパックプロバイオティクス
NIZO
ウィンクローブのプロバイオティクス
BJPラボラトリーズ
ルイナ・バイオ
リストラボ
マトリックス・バイオサイエンス

ページTOPに戻る

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Living Biological Drugs Market Size 2018-2029
2.1.2 Living Biological Drugs Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Living Biological Drugs Segment by Type
2.2.1 Single Strain
2.2.2 Multi Strain
2.2.3 Co-Culture
2.3 Living Biological Drugs Market Size by Type
2.3.1 Living Biological Drugs Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Living Biological Drugs Market Size Market Share by Type (2018-2023)
2.4 Living Biological Drugs Segment by Application
2.4.1 Digestive System
2.4.2 Urinary System
2.4.3 Skin System
2.5 Living Biological Drugs Market Size by Application
2.5.1 Living Biological Drugs Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Living Biological Drugs Market Size Market Share by Application (2018-2023)
3 Living Biological Drugs Market Size by Player
3.1 Living Biological Drugs Market Size Market Share by Players
3.1.1 Global Living Biological Drugs Revenue by Players (2018-2023)
3.1.2 Global Living Biological Drugs Revenue Market Share by Players (2018-2023)
3.2 Global Living Biological Drugs Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Living Biological Drugs by Regions
4.1 Living Biological Drugs Market Size by Regions (2018-2023)
4.2 Americas Living Biological Drugs Market Size Growth (2018-2023)
4.3 APAC Living Biological Drugs Market Size Growth (2018-2023)
4.4 Europe Living Biological Drugs Market Size Growth (2018-2023)
4.5 Middle East & Africa Living Biological Drugs Market Size Growth (2018-2023)
5 Americas
5.1 Americas Living Biological Drugs Market Size by Country (2018-2023)
5.2 Americas Living Biological Drugs Market Size by Type (2018-2023)
5.3 Americas Living Biological Drugs Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Living Biological Drugs Market Size by Region (2018-2023)
6.2 APAC Living Biological Drugs Market Size by Type (2018-2023)
6.3 APAC Living Biological Drugs Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Living Biological Drugs by Country (2018-2023)
7.2 Europe Living Biological Drugs Market Size by Type (2018-2023)
7.3 Europe Living Biological Drugs Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Living Biological Drugs by Region (2018-2023)
8.2 Middle East & Africa Living Biological Drugs Market Size by Type (2018-2023)
8.3 Middle East & Africa Living Biological Drugs Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Living Biological Drugs Market Forecast
10.1 Global Living Biological Drugs Forecast by Regions (2024-2029)
10.1.1 Global Living Biological Drugs Forecast by Regions (2024-2029)
10.1.2 Americas Living Biological Drugs Forecast
10.1.3 APAC Living Biological Drugs Forecast
10.1.4 Europe Living Biological Drugs Forecast
10.1.5 Middle East & Africa Living Biological Drugs Forecast
10.2 Americas Living Biological Drugs Forecast by Country (2024-2029)
10.2.1 United States Living Biological Drugs Market Forecast
10.2.2 Canada Living Biological Drugs Market Forecast
10.2.3 Mexico Living Biological Drugs Market Forecast
10.2.4 Brazil Living Biological Drugs Market Forecast
10.3 APAC Living Biological Drugs Forecast by Region (2024-2029)
10.3.1 China Living Biological Drugs Market Forecast
10.3.2 Japan Living Biological Drugs Market Forecast
10.3.3 Korea Living Biological Drugs Market Forecast
10.3.4 Southeast Asia Living Biological Drugs Market Forecast
10.3.5 India Living Biological Drugs Market Forecast
10.3.6 Australia Living Biological Drugs Market Forecast
10.4 Europe Living Biological Drugs Forecast by Country (2024-2029)
10.4.1 Germany Living Biological Drugs Market Forecast
10.4.2 France Living Biological Drugs Market Forecast
10.4.3 UK Living Biological Drugs Market Forecast
10.4.4 Italy Living Biological Drugs Market Forecast
10.4.5 Russia Living Biological Drugs Market Forecast
10.5 Middle East & Africa Living Biological Drugs Forecast by Region (2024-2029)
10.5.1 Egypt Living Biological Drugs Market Forecast
10.5.2 South Africa Living Biological Drugs Market Forecast
10.5.3 Israel Living Biological Drugs Market Forecast
10.5.4 Turkey Living Biological Drugs Market Forecast
10.5.5 GCC Countries Living Biological Drugs Market Forecast
10.6 Global Living Biological Drugs Forecast by Type (2024-2029)
10.7 Global Living Biological Drugs Forecast by Application (2024-2029)

11 Key Players Analysis
11.1 Ardeypharman
11.1.1 Ardeypharman Company Information
11.1.2 Ardeypharman Living Biological Drugs Product Offered
11.1.3 Ardeypharman Living Biological Drugs Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Ardeypharman Main Business Overview
11.1.5 Ardeypharman Latest Developments
11.2 Miyarisan Pharmaceutical
11.2.1 Miyarisan Pharmaceutical Company Information
11.2.2 Miyarisan Pharmaceutical Living Biological Drugs Product Offered
11.2.3 Miyarisan Pharmaceutical Living Biological Drugs Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Miyarisan Pharmaceutical Main Business Overview
11.2.5 Miyarisan Pharmaceutical Latest Developments
11.3 Ferring Pharmaceuticals
11.3.1 Ferring Pharmaceuticals Company Information
11.3.2 Ferring Pharmaceuticals Living Biological Drugs Product Offered
11.3.3 Ferring Pharmaceuticals Living Biological Drugs Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Ferring Pharmaceuticals Main Business Overview
11.3.5 Ferring Pharmaceuticals Latest Developments
11.4 Seres Therapeutics
11.4.1 Seres Therapeutics Company Information
11.4.2 Seres Therapeutics Living Biological Drugs Product Offered
11.4.3 Seres Therapeutics Living Biological Drugs Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Seres Therapeutics Main Business Overview
11.4.5 Seres Therapeutics Latest Developments
11.5 Infant Bacterial Therapeutics
11.5.1 Infant Bacterial Therapeutics Company Information
11.5.2 Infant Bacterial Therapeutics Living Biological Drugs Product Offered
11.5.3 Infant Bacterial Therapeutics Living Biological Drugs Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Infant Bacterial Therapeutics Main Business Overview
11.5.5 Infant Bacterial Therapeutics Latest Developments
11.6 Osel
11.6.1 Osel Company Information
11.6.2 Osel Living Biological Drugs Product Offered
11.6.3 Osel Living Biological Drugs Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Osel Main Business Overview
11.6.5 Osel Latest Developments
11.7 Takeda
11.7.1 Takeda Company Information
11.7.2 Takeda Living Biological Drugs Product Offered
11.7.3 Takeda Living Biological Drugs Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 Takeda Main Business Overview
11.7.5 Takeda Latest Developments
11.8 AOBiome
11.8.1 AOBiome Company Information
11.8.2 AOBiome Living Biological Drugs Product Offered
11.8.3 AOBiome Living Biological Drugs Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 AOBiome Main Business Overview
11.8.5 AOBiome Latest Developments
11.9 Synlogic
11.9.1 Synlogic Company Information
11.9.2 Synlogic Living Biological Drugs Product Offered
11.9.3 Synlogic Living Biological Drugs Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 Synlogic Main Business Overview
11.9.5 Synlogic Latest Developments
11.10 Finch Therapeutics
11.10.1 Finch Therapeutics Company Information
11.10.2 Finch Therapeutics Living Biological Drugs Product Offered
11.10.3 Finch Therapeutics Living Biological Drugs Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 Finch Therapeutics Main Business Overview
11.10.5 Finch Therapeutics Latest Developments
11.11 Capsugel
11.11.1 Capsugel Company Information
11.11.2 Capsugel Living Biological Drugs Product Offered
11.11.3 Capsugel Living Biological Drugs Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 Capsugel Main Business Overview
11.11.5 Capsugel Latest Developments
11.12 Jeneil Biotech
11.12.1 Jeneil Biotech Company Information
11.12.2 Jeneil Biotech Living Biological Drugs Product Offered
11.12.3 Jeneil Biotech Living Biological Drugs Revenue, Gross Margin and Market Share (2018-2023)
11.12.4 Jeneil Biotech Main Business Overview
11.12.5 Jeneil Biotech Latest Developments
11.13 UAS Labs
11.13.1 UAS Labs Company Information
11.13.2 UAS Labs Living Biological Drugs Product Offered
11.13.3 UAS Labs Living Biological Drugs Revenue, Gross Margin and Market Share (2018-2023)
11.13.4 UAS Labs Main Business Overview
11.13.5 UAS Labs Latest Developments
11.14 Biose
11.14.1 Biose Company Information
11.14.2 Biose Living Biological Drugs Product Offered
11.14.3 Biose Living Biological Drugs Revenue, Gross Margin and Market Share (2018-2023)
11.14.4 Biose Main Business Overview
11.14.5 Biose Latest Developments
11.15 Cerbios-Pharma
11.15.1 Cerbios-Pharma Company Information
11.15.2 Cerbios-Pharma Living Biological Drugs Product Offered
11.15.3 Cerbios-Pharma Living Biological Drugs Revenue, Gross Margin and Market Share (2018-2023)
11.15.4 Cerbios-Pharma Main Business Overview
11.15.5 Cerbios-Pharma Latest Developments
11.16 Inpac Probiotics
11.16.1 Inpac Probiotics Company Information
11.16.2 Inpac Probiotics Living Biological Drugs Product Offered
11.16.3 Inpac Probiotics Living Biological Drugs Revenue, Gross Margin and Market Share (2018-2023)
11.16.4 Inpac Probiotics Main Business Overview
11.16.5 Inpac Probiotics Latest Developments
11.17 NIZO
11.17.1 NIZO Company Information
11.17.2 NIZO Living Biological Drugs Product Offered
11.17.3 NIZO Living Biological Drugs Revenue, Gross Margin and Market Share (2018-2023)
11.17.4 NIZO Main Business Overview
11.17.5 NIZO Latest Developments
11.18 Winclove Probiotics
11.18.1 Winclove Probiotics Company Information
11.18.2 Winclove Probiotics Living Biological Drugs Product Offered
11.18.3 Winclove Probiotics Living Biological Drugs Revenue, Gross Margin and Market Share (2018-2023)
11.18.4 Winclove Probiotics Main Business Overview
11.18.5 Winclove Probiotics Latest Developments
11.19 BJP Laboratories
11.19.1 BJP Laboratories Company Information
11.19.2 BJP Laboratories Living Biological Drugs Product Offered
11.19.3 BJP Laboratories Living Biological Drugs Revenue, Gross Margin and Market Share (2018-2023)
11.19.4 BJP Laboratories Main Business Overview
11.19.5 BJP Laboratories Latest Developments
11.20 Luina Bio
11.20.1 Luina Bio Company Information
11.20.2 Luina Bio Living Biological Drugs Product Offered
11.20.3 Luina Bio Living Biological Drugs Revenue, Gross Margin and Market Share (2018-2023)
11.20.4 Luina Bio Main Business Overview
11.20.5 Luina Bio Latest Developments
11.21 List Labs
11.21.1 List Labs Company Information
11.21.2 List Labs Living Biological Drugs Product Offered
11.21.3 List Labs Living Biological Drugs Revenue, Gross Margin and Market Share (2018-2023)
11.21.4 List Labs Main Business Overview
11.21.5 List Labs Latest Developments
11.22 MatriSys Bioscience
11.22.1 MatriSys Bioscience Company Information
11.22.2 MatriSys Bioscience Living Biological Drugs Product Offered
11.22.3 MatriSys Bioscience Living Biological Drugs Revenue, Gross Margin and Market Share (2018-2023)
11.22.4 MatriSys Bioscience Main Business Overview
11.22.5 MatriSys Bioscience Latest Developments
12 Research Findings and Conclusion

ページTOPに戻る

図表リスト

List of Tables
Table 1. Living Biological Drugs Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Single Strain
Table 3. Major Players of Multi Strain
Table 4. Major Players of Co-Culture
Table 5. Living Biological Drugs Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 6. Global Living Biological Drugs Market Size by Type (2018-2023) & ($ Millions)
Table 7. Global Living Biological Drugs Market Size Market Share by Type (2018-2023)
Table 8. Living Biological Drugs Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 9. Global Living Biological Drugs Market Size by Application (2018-2023) & ($ Millions)
Table 10. Global Living Biological Drugs Market Size Market Share by Application (2018-2023)
Table 11. Global Living Biological Drugs Revenue by Players (2018-2023) & ($ Millions)
Table 12. Global Living Biological Drugs Revenue Market Share by Player (2018-2023)
Table 13. Living Biological Drugs Key Players Head office and Products Offered
Table 14. Living Biological Drugs Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Living Biological Drugs Market Size by Regions 2018-2023 & ($ Millions)
Table 18. Global Living Biological Drugs Market Size Market Share by Regions (2018-2023)
Table 19. Global Living Biological Drugs Revenue by Country/Region (2018-2023) & ($ millions)
Table 20. Global Living Biological Drugs Revenue Market Share by Country/Region (2018-2023)
Table 21. Americas Living Biological Drugs Market Size by Country (2018-2023) & ($ Millions)
Table 22. Americas Living Biological Drugs Market Size Market Share by Country (2018-2023)
Table 23. Americas Living Biological Drugs Market Size by Type (2018-2023) & ($ Millions)
Table 24. Americas Living Biological Drugs Market Size Market Share by Type (2018-2023)
Table 25. Americas Living Biological Drugs Market Size by Application (2018-2023) & ($ Millions)
Table 26. Americas Living Biological Drugs Market Size Market Share by Application (2018-2023)
Table 27. APAC Living Biological Drugs Market Size by Region (2018-2023) & ($ Millions)
Table 28. APAC Living Biological Drugs Market Size Market Share by Region (2018-2023)
Table 29. APAC Living Biological Drugs Market Size by Type (2018-2023) & ($ Millions)
Table 30. APAC Living Biological Drugs Market Size Market Share by Type (2018-2023)
Table 31. APAC Living Biological Drugs Market Size by Application (2018-2023) & ($ Millions)
Table 32. APAC Living Biological Drugs Market Size Market Share by Application (2018-2023)
Table 33. Europe Living Biological Drugs Market Size by Country (2018-2023) & ($ Millions)
Table 34. Europe Living Biological Drugs Market Size Market Share by Country (2018-2023)
Table 35. Europe Living Biological Drugs Market Size by Type (2018-2023) & ($ Millions)
Table 36. Europe Living Biological Drugs Market Size Market Share by Type (2018-2023)
Table 37. Europe Living Biological Drugs Market Size by Application (2018-2023) & ($ Millions)
Table 38. Europe Living Biological Drugs Market Size Market Share by Application (2018-2023)
Table 39. Middle East & Africa Living Biological Drugs Market Size by Region (2018-2023) & ($ Millions)
Table 40. Middle East & Africa Living Biological Drugs Market Size Market Share by Region (2018-2023)
Table 41. Middle East & Africa Living Biological Drugs Market Size by Type (2018-2023) & ($ Millions)
Table 42. Middle East & Africa Living Biological Drugs Market Size Market Share by Type (2018-2023)
Table 43. Middle East & Africa Living Biological Drugs Market Size by Application (2018-2023) & ($ Millions)
Table 44. Middle East & Africa Living Biological Drugs Market Size Market Share by Application (2018-2023)
Table 45. Key Market Drivers & Growth Opportunities of Living Biological Drugs
Table 46. Key Market Challenges & Risks of Living Biological Drugs
Table 47. Key Industry Trends of Living Biological Drugs
Table 48. Global Living Biological Drugs Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 49. Global Living Biological Drugs Market Size Market Share Forecast by Regions (2024-2029)
Table 50. Global Living Biological Drugs Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 51. Global Living Biological Drugs Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 52. Ardeypharman Details, Company Type, Living Biological Drugs Area Served and Its Competitors
Table 53. Ardeypharman Living Biological Drugs Product Offered
Table 54. Ardeypharman Living Biological Drugs Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 55. Ardeypharman Main Business
Table 56. Ardeypharman Latest Developments
Table 57. Miyarisan Pharmaceutical Details, Company Type, Living Biological Drugs Area Served and Its Competitors
Table 58. Miyarisan Pharmaceutical Living Biological Drugs Product Offered
Table 59. Miyarisan Pharmaceutical Main Business
Table 60. Miyarisan Pharmaceutical Living Biological Drugs Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 61. Miyarisan Pharmaceutical Latest Developments
Table 62. Ferring Pharmaceuticals Details, Company Type, Living Biological Drugs Area Served and Its Competitors
Table 63. Ferring Pharmaceuticals Living Biological Drugs Product Offered
Table 64. Ferring Pharmaceuticals Main Business
Table 65. Ferring Pharmaceuticals Living Biological Drugs Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 66. Ferring Pharmaceuticals Latest Developments
Table 67. Seres Therapeutics Details, Company Type, Living Biological Drugs Area Served and Its Competitors
Table 68. Seres Therapeutics Living Biological Drugs Product Offered
Table 69. Seres Therapeutics Main Business
Table 70. Seres Therapeutics Living Biological Drugs Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 71. Seres Therapeutics Latest Developments
Table 72. Infant Bacterial Therapeutics Details, Company Type, Living Biological Drugs Area Served and Its Competitors
Table 73. Infant Bacterial Therapeutics Living Biological Drugs Product Offered
Table 74. Infant Bacterial Therapeutics Main Business
Table 75. Infant Bacterial Therapeutics Living Biological Drugs Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 76. Infant Bacterial Therapeutics Latest Developments
Table 77. Osel Details, Company Type, Living Biological Drugs Area Served and Its Competitors
Table 78. Osel Living Biological Drugs Product Offered
Table 79. Osel Main Business
Table 80. Osel Living Biological Drugs Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 81. Osel Latest Developments
Table 82. Takeda Details, Company Type, Living Biological Drugs Area Served and Its Competitors
Table 83. Takeda Living Biological Drugs Product Offered
Table 84. Takeda Main Business
Table 85. Takeda Living Biological Drugs Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 86. Takeda Latest Developments
Table 87. AOBiome Details, Company Type, Living Biological Drugs Area Served and Its Competitors
Table 88. AOBiome Living Biological Drugs Product Offered
Table 89. AOBiome Main Business
Table 90. AOBiome Living Biological Drugs Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 91. AOBiome Latest Developments
Table 92. Synlogic Details, Company Type, Living Biological Drugs Area Served and Its Competitors
Table 93. Synlogic Living Biological Drugs Product Offered
Table 94. Synlogic Main Business
Table 95. Synlogic Living Biological Drugs Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 96. Synlogic Latest Developments
Table 97. Finch Therapeutics Details, Company Type, Living Biological Drugs Area Served and Its Competitors
Table 98. Finch Therapeutics Living Biological Drugs Product Offered
Table 99. Finch Therapeutics Main Business
Table 100. Finch Therapeutics Living Biological Drugs Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 101. Finch Therapeutics Latest Developments
Table 102. Capsugel Details, Company Type, Living Biological Drugs Area Served and Its Competitors
Table 103. Capsugel Living Biological Drugs Product Offered
Table 104. Capsugel Living Biological Drugs Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 105. Capsugel Main Business
Table 106. Capsugel Latest Developments
Table 107. Jeneil Biotech Details, Company Type, Living Biological Drugs Area Served and Its Competitors
Table 108. Jeneil Biotech Living Biological Drugs Product Offered
Table 109. Jeneil Biotech Main Business
Table 110. Jeneil Biotech Living Biological Drugs Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 111. Jeneil Biotech Latest Developments
Table 112. UAS Labs Details, Company Type, Living Biological Drugs Area Served and Its Competitors
Table 113. UAS Labs Living Biological Drugs Product Offered
Table 114. UAS Labs Main Business
Table 115. UAS Labs Living Biological Drugs Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 116. UAS Labs Latest Developments
Table 117. Biose Details, Company Type, Living Biological Drugs Area Served and Its Competitors
Table 118. Biose Living Biological Drugs Product Offered
Table 119. Biose Main Business
Table 120. Biose Living Biological Drugs Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 121. Biose Latest Developments
Table 122. Cerbios-Pharma Details, Company Type, Living Biological Drugs Area Served and Its Competitors
Table 123. Cerbios-Pharma Living Biological Drugs Product Offered
Table 124. Cerbios-Pharma Main Business
Table 125. Cerbios-Pharma Living Biological Drugs Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 126. Cerbios-Pharma Latest Developments
Table 127. Inpac Probiotics Details, Company Type, Living Biological Drugs Area Served and Its Competitors
Table 128. Inpac Probiotics Living Biological Drugs Product Offered
Table 129. Inpac Probiotics Main Business
Table 130. Inpac Probiotics Living Biological Drugs Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 131. Inpac Probiotics Latest Developments
Table 132. NIZO Details, Company Type, Living Biological Drugs Area Served and Its Competitors
Table 133. NIZO Living Biological Drugs Product Offered
Table 134. NIZO Main Business
Table 135. NIZO Living Biological Drugs Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 136. NIZO Latest Developments
Table 137. Winclove Probiotics Details, Company Type, Living Biological Drugs Area Served and Its Competitors
Table 138. Winclove Probiotics Living Biological Drugs Product Offered
Table 139. Winclove Probiotics Main Business
Table 140. Winclove Probiotics Living Biological Drugs Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 141. Winclove Probiotics Latest Developments
Table 142. BJP Laboratories Details, Company Type, Living Biological Drugs Area Served and Its Competitors
Table 143. BJP Laboratories Living Biological Drugs Product Offered
Table 144. BJP Laboratories Main Business
Table 145. BJP Laboratories Living Biological Drugs Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 146. BJP Laboratories Latest Developments
Table 147. Luina Bio Details, Company Type, Living Biological Drugs Area Served and Its Competitors
Table 148. Luina Bio Living Biological Drugs Product Offered
Table 149. Luina Bio Main Business
Table 150. Luina Bio Living Biological Drugs Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 151. Luina Bio Latest Developments
Table 152. List Labs Details, Company Type, Living Biological Drugs Area Served and Its Competitors
Table 153. List Labs Living Biological Drugs Product Offered
Table 154. List Labs Living Biological Drugs Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 155. List Labs Main Business
Table 156. List Labs Latest Developments
Table 157. MatriSys Bioscience Details, Company Type, Living Biological Drugs Area Served and Its Competitors
Table 158. MatriSys Bioscience Living Biological Drugs Product Offered
Table 159. MatriSys Bioscience Main Business
Table 160. MatriSys Bioscience Living Biological Drugs Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 161. MatriSys Bioscience Latest Developments
List of Figures
Figure 1. Living Biological Drugs Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Living Biological Drugs Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Living Biological Drugs Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Living Biological Drugs Sales Market Share by Country/Region (2022)
Figure 8. Living Biological Drugs Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Living Biological Drugs Market Size Market Share by Type in 2022
Figure 10. Living Biological Drugs in Digestive System
Figure 11. Global Living Biological Drugs Market: Digestive System (2018-2023) & ($ Millions)
Figure 12. Living Biological Drugs in Urinary System
Figure 13. Global Living Biological Drugs Market: Urinary System (2018-2023) & ($ Millions)
Figure 14. Living Biological Drugs in Skin System
Figure 15. Global Living Biological Drugs Market: Skin System (2018-2023) & ($ Millions)
Figure 16. Global Living Biological Drugs Market Size Market Share by Application in 2022
Figure 17. Global Living Biological Drugs Revenue Market Share by Player in 2022
Figure 18. Global Living Biological Drugs Market Size Market Share by Regions (2018-2023)
Figure 19. Americas Living Biological Drugs Market Size 2018-2023 ($ Millions)
Figure 20. APAC Living Biological Drugs Market Size 2018-2023 ($ Millions)
Figure 21. Europe Living Biological Drugs Market Size 2018-2023 ($ Millions)
Figure 22. Middle East & Africa Living Biological Drugs Market Size 2018-2023 ($ Millions)
Figure 23. Americas Living Biological Drugs Value Market Share by Country in 2022
Figure 24. United States Living Biological Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 25. Canada Living Biological Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 26. Mexico Living Biological Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 27. Brazil Living Biological Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 28. APAC Living Biological Drugs Market Size Market Share by Region in 2022
Figure 29. APAC Living Biological Drugs Market Size Market Share by Type in 2022
Figure 30. APAC Living Biological Drugs Market Size Market Share by Application in 2022
Figure 31. China Living Biological Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 32. Japan Living Biological Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 33. Korea Living Biological Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 34. Southeast Asia Living Biological Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 35. India Living Biological Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 36. Australia Living Biological Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 37. Europe Living Biological Drugs Market Size Market Share by Country in 2022
Figure 38. Europe Living Biological Drugs Market Size Market Share by Type (2018-2023)
Figure 39. Europe Living Biological Drugs Market Size Market Share by Application (2018-2023)
Figure 40. Germany Living Biological Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 41. France Living Biological Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 42. UK Living Biological Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 43. Italy Living Biological Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 44. Russia Living Biological Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 45. Middle East & Africa Living Biological Drugs Market Size Market Share by Region (2018-2023)
Figure 46. Middle East & Africa Living Biological Drugs Market Size Market Share by Type (2018-2023)
Figure 47. Middle East & Africa Living Biological Drugs Market Size Market Share by Application (2018-2023)
Figure 48. Egypt Living Biological Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 49. South Africa Living Biological Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 50. Israel Living Biological Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 51. Turkey Living Biological Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 52. GCC Country Living Biological Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 53. Americas Living Biological Drugs Market Size 2024-2029 ($ Millions)
Figure 54. APAC Living Biological Drugs Market Size 2024-2029 ($ Millions)
Figure 55. Europe Living Biological Drugs Market Size 2024-2029 ($ Millions)
Figure 56. Middle East & Africa Living Biological Drugs Market Size 2024-2029 ($ Millions)
Figure 57. United States Living Biological Drugs Market Size 2024-2029 ($ Millions)
Figure 58. Canada Living Biological Drugs Market Size 2024-2029 ($ Millions)
Figure 59. Mexico Living Biological Drugs Market Size 2024-2029 ($ Millions)
Figure 60. Brazil Living Biological Drugs Market Size 2024-2029 ($ Millions)
Figure 61. China Living Biological Drugs Market Size 2024-2029 ($ Millions)
Figure 62. Japan Living Biological Drugs Market Size 2024-2029 ($ Millions)
Figure 63. Korea Living Biological Drugs Market Size 2024-2029 ($ Millions)
Figure 64. Southeast Asia Living Biological Drugs Market Size 2024-2029 ($ Millions)
Figure 65. India Living Biological Drugs Market Size 2024-2029 ($ Millions)
Figure 66. Australia Living Biological Drugs Market Size 2024-2029 ($ Millions)
Figure 67. Germany Living Biological Drugs Market Size 2024-2029 ($ Millions)
Figure 68. France Living Biological Drugs Market Size 2024-2029 ($ Millions)
Figure 69. UK Living Biological Drugs Market Size 2024-2029 ($ Millions)
Figure 70. Italy Living Biological Drugs Market Size 2024-2029 ($ Millions)
Figure 71. Russia Living Biological Drugs Market Size 2024-2029 ($ Millions)
Figure 72. Spain Living Biological Drugs Market Size 2024-2029 ($ Millions)
Figure 73. Egypt Living Biological Drugs Market Size 2024-2029 ($ Millions)
Figure 74. South Africa Living Biological Drugs Market Size 2024-2029 ($ Millions)
Figure 75. Israel Living Biological Drugs Market Size 2024-2029 ($ Millions)
Figure 76. Turkey Living Biological Drugs Market Size 2024-2029 ($ Millions)
Figure 77. GCC Countries Living Biological Drugs Market Size 2024-2029 ($ Millions)
Figure 78. Global Living Biological Drugs Market Size Market Share Forecast by Type (2024-2029)
Figure 79. Global Living Biological Drugs Market Size Market Share Forecast by Application (2024-2029)

ページTOPに戻る

Table of Contents
List of Tables/Graphs

Summary

LPI (LP Information)' newest research report, the “Living Biological Drugs Industry Forecast” looks at past sales and reviews total world Living Biological Drugs sales in 2022, providing a comprehensive analysis by region and market sector of projected Living Biological Drugs sales for 2023 through 2029. With Living Biological Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Living Biological Drugs industry.
This Insight Report provides a comprehensive analysis of the global Living Biological Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Living Biological Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Living Biological Drugs market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Living Biological Drugs and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Living Biological Drugs.
The global Living Biological Drugs market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Living Biological Drugs is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Living Biological Drugs is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Living Biological Drugs is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Living Biological Drugs players cover Ardeypharman, Miyarisan Pharmaceutical, Ferring Pharmaceuticals, Seres Therapeutics, Infant Bacterial Therapeutics, Osel, Takeda, AOBiome and Synlogic, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Living Biological Drugs market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
Single Strain
Multi Strain
Co-Culture
Segmentation by application
Digestive System
Urinary System
Skin System
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Ardeypharman
Miyarisan Pharmaceutical
Ferring Pharmaceuticals
Seres Therapeutics
Infant Bacterial Therapeutics
Osel
Takeda
AOBiome
Synlogic
Finch Therapeutics
Capsugel
Jeneil Biotech
UAS Labs
Biose
Cerbios-Pharma
Inpac Probiotics
NIZO
Winclove Probiotics
BJP Laboratories
Luina Bio
List Labs
MatriSys Bioscience

ページTOPに戻る

List of Tables/Graphs

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野（ソフトウェア）の最新刊レポート

LP Information社のサービス・ソフトウェア分野での最新刊レポート

本レポートと同じKEY WORD（）の最新刊レポート

本レポートと同じKEY WORDの最新刊レポートはありません。

よくあるご質問

LP Information社はどのような調査会社ですか?

LP Informationは通信、エネルギー、医薬をはじめとする広範な市場の調査とレポート出版を行っている調査会社です。もっと見る

調査レポートの納品までの日数はどの程度ですか?

在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。

注文の手続きはどのようになっていますか?

1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。

お支払方法の方法はどのようになっていますか?

納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。

データリソース社はどのような会社ですか?

当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。

世界の生体用医薬品市場の成長（現状と展望）2023-2029年

サマリー

目次

図表リスト

Summary

Table of Contents

List of Tables/Graphs

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

本レポートと同分野（ソフトウェア）の最新刊レポート

LP Information社のサービス・ソフトウェア分野での最新刊レポート

本レポートと同じKEY WORD（）の最新刊レポート

よくあるご質問

LP Information社はどのような調査会社ですか?

調査レポートの納品までの日数はどの程度ですか?

注文の手続きはどのようになっていますか?

お支払方法の方法はどのようになっていますか?

データリソース社はどのような会社ですか?